Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126357591 | 12635759 | 1 | I | 20160628 | 20160713 | 20160809 | 20160809 | PER | US-PFIZER INC-2016345075 | PFIZER | 67.00 | YR | F | Y | 86.00000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126357591 | 12635759 | 1 | PS | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | Oral | 150 UG, 1X/DAY | N | 21301 | 150 | UG | TABLET | QD | |||||
| 126357591 | 12635759 | 2 | I | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | 137 UG, UNK | N | 21301 | 137 | UG | TABLET | |||||||
| 126357591 | 12635759 | 3 | I | CAFFEINE. | CAFFEINE | 1 | UNK | N | 0 | ||||||||||
| 126357591 | 12635759 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 400 UG, 4X/DAY, (ONE IN MORNING AND THREE IN THE EVENING BY MOUTH) | 0 | 400 | UG | CAPSULE | QID | ||||||
| 126357591 | 12635759 | 5 | C | LOSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | UNK, 1X/DAY,(HYDROCHLOROTHIAZIDE 125MG, LOSARTAN POTASSIUM 100MG) | 0 | TABLET | QD | ||||||||
| 126357591 | 12635759 | 6 | C | CELECOXIB. | CELECOXIB | 1 | Oral | 200 MG, 1X/DAY | 0 | 200 | MG | CAPSULE | QD | ||||||
| 126357591 | 12635759 | 7 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126357591 | 12635759 | 1 | Hypothyroidism |
| 126357591 | 12635759 | 4 | Spinal column stenosis |
| 126357591 | 12635759 | 5 | Hypertension |
| 126357591 | 12635759 | 6 | Arthritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126357591 | 12635759 | Blood thyroid stimulating hormone abnormal | |
| 126357591 | 12635759 | Blood thyroid stimulating hormone decreased | |
| 126357591 | 12635759 | Drug ineffective | |
| 126357591 | 12635759 | Potentiating drug interaction | |
| 126357591 | 12635759 | Thyroxine free abnormal | |
| 126357591 | 12635759 | Thyroxine increased | |
| 126357591 | 12635759 | Tri-iodothyronine free abnormal | |
| 126357591 | 12635759 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126357591 | 12635759 | 4 | 2006 | 0 | ||
| 126357591 | 12635759 | 5 | 2014 | 0 | ||
| 126357591 | 12635759 | 6 | 2013 | 0 | ||
| 126357591 | 12635759 | 7 | 2006 | 0 |